EAM Investors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-349,000
| Closed | -$768K | – | 289 |
|
|
2025
Q1 | $768K | Buy |
+349,000
| New | +$768K | 0.13% | 185 |
|
|
2024
Q3 | – | Sell |
-274,076
| Closed | -$959K | – | 284 |
|
|
2024
Q2 | $959K | Sell |
274,076
-434
| -0.2% | -$1.52K | 0.16% | 167 |
|
|
2024
Q1 | $760K | Buy |
+274,510
| New | +$760K | 0.12% | 209 |
|
|
2018
Q4 | – | Sell |
-85,542
| Closed | -$2.71M | – | 278 |
|
|
2018
Q3 | $2.71M | Sell |
85,542
-9,989
| -10% | -$316K | 0.4% | 124 |
|
|
2018
Q2 | $3.71M | Sell |
95,531
-84,380
| -47% | -$3.28M | 0.59% | 40 |
|
|
2018
Q1 | $4.97M | Buy |
+179,911
| New | +$4.97M | 0.83% | 3 |
|
|
2016
Q3 | – | Sell |
-33,332
| Closed | -$602K | – | 325 |
|
|
2016
Q2 | $602K | Sell |
33,332
-1,923
| -5% | -$34.7K | 0.09% | 290 |
|
|
2016
Q1 | $669K | Sell |
35,255
-5,527
| -14% | -$105K | 0.1% | 291 |
|
|
2015
Q4 | $1.09M | Sell |
40,782
-918
| -2% | -$24.5K | 0.14% | 260 |
|
|
2015
Q3 | $1.02M | Sell |
41,700
-9,540
| -19% | -$233K | 0.16% | 259 |
|
|
2015
Q2 | $1.6M | Sell |
51,240
-179,021
| -78% | -$5.58M | 0.19% | 217 |
|
|
2015
Q1 | $3.35M | Buy |
+230,261
| New | +$3.35M | 0.39% | 110 |
|